Evidence map›Paper›PMID 20485503›Full record

ArticlePloS one2010

Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats.

Jinze Xu, Arnold Y Seo, Darya A Vorobyeva, Christy S Carter, Stephen D Anton, Angela M S Lezza, Christiaan Leeuwenburgh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Trends in ginseng research in 2010.Journal of ginseng research · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jinze XuDivision of Biology of Aging, Genomics and Biomarkers Core of The Institute on Aging, Department of Aging and Geriatric Research, University of Florida, Gainesville, Florida, United States of America. jxu@aging.ufl.edu
Arnold Y Seo
Darya A Vorobyeva
Christy S Carter
Stephen D Anton
Angela M S Lezza
Christiaan Leeuwenburgh
University of Florida · USInstitute on Aging · USUniversity of Bari Aldo Moro · IT

Funding

University of Florida Older Americans Independence Center (OAIC)P30AG028740 · NIA · UNIVERSITY OF FLORIDA · PI Karyn A Esser, Todd Manini · 2007 to 2026
$22.8M
MOLECULAR MECHANISMS OF OXIDATIVE STRESS IN AGING MUSCLER01AG017994 · NIA · UNIVERSITY OF FLORIDA · PI LEEUWENBURGH, CHRISTIAAN · 2000 to 2012
$2.9M
Investigations of botanicals on food intake, satiety, weight loss, and oxidativeK23AT004251 · NCCIH · UNIVERSITY OF FLORIDA · PI ANTON, STEPHEN D · 2009 to 2013
$575k
NCCIH NIH HHS 1K23AT004251NCCIH NIH HHS K23 AT004251NIA NIH HHS 1 P30 AG028740NIA NIH HHS AG17994NIA NIH HHS P30 AG028740NIA NIH HHS R01 AG017994
6 · The paper itself

Abstract

backgroundMitochondrial dysfunction and oxidative stress are central mechanisms underlying the aging process and the pathogenesis of many age-related diseases. Selected antioxidants and specific combinations of nutritional compounds could target many biochemical pathways that affect both oxidative stress and mitochondrial function and, thereby, preserve or enhance physical performance. METHODOLOGY/PRINCIPAL

findingsIn this study, we evaluated the potential anti-aging benefits of a Q-ter based nutritional mixture (commercially known as Eufortyn) mainly containing the following compounds: terclatrated coenzyme Q(10) (Q-ter), creatine and a standardized ginseng extract. We found that Eufortyn supplementation significantly ameliorated the age-associated decreases in grip strength and gastrocnemius subsarcolemmal mitochondria Ca(2+) retention capacity when initiated in male Fischer344 x Brown Norway rats at 21 months, but not 29 months, of age. Moreover, the increases in muscle RNA oxidation and subsarcolemmal mitochondrial protein carbonyl levels, as well as the decline of total urine antioxidant power, which develop late in life, were mitigated by Eufortyn supplementation in rats at 29 months of age. CONCLUSIONS/SIGNIFICANCE: These data imply that Eufortyn is efficacious in reducing oxidative damage, improving the age-related mitochondrial functional decline, and preserving physical performance when initiated in animals at early midlife (21 months). The efficacy varied, however, according to the age at which the supplementation was provided, as initiation in late middle age (29 months) was incapable of restoring grip strength and mitochondrial function. Therefore, the Eufortyn supplementation may be particularly beneficial when initiated prior to major biological and functional declines that appear to occur with advancing age.

Indexed as

Dietary SupplementsNutritional Physiological PhenomenaOxidative StressAnimalsAntioxidantsBody WeightCalciumCrosses, GeneticDNAFeeding BehaviorFemaleHand StrengthIronMaleMitochondriaMusclesAntioxidantsCalciumcoenzyme Q10DNAIronRNAUbiquinone

Identifiers

PMID20485503
PMCPMC2868025
OpenAlexW2055907651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.